Cohen R I, Hassell A M, Marzouk K, Marini C, Liu S F, Scharf S M
Division of Pulmonary and Critical Care Medicine, The Long Island Jewish Medical Center, New Hyde Park, New York 11040, USA.
Am J Respir Crit Care Med. 2001 Nov 15;164(10 Pt 1):1890-5. doi: 10.1164/ajrccm.164.10.2103140.
Nitric oxide (NO) is postulated to play a key role in the pathophysiology of renal failure in sepsis. Whether the renal effects of increased NO are beneficial or harmful remains unclear. In a porcine model of lipopolysaccharide (LPS)-induced shock, we evaluated the effect of LPS on glomerular filtration rate (GFR) and renal blood flow (RBF). We then administered the nonselective nitric oxide synthase (NOS) inhibitor N(G)-L-arginine methyl ester (L-NAME), and compared its effects on GFR and RBF with those of S-methylisothiourea (SMT), a selective NOS inhibitor, and those of saline. We postulated that SMT, by maintaining constitutive NO, would be more beneficial than either L-NAME or saline. LPS infusion decreased mean arterial pressure (MAP), and increased cardiac output, RBF, and medullary NO content. The increased RBF was diverted to the medulla. There was no evidence of renal dysfunction in the saline-resuscitated group. Both NOS inhibitors increased MAP but decreased RBF, but only L-NAME reduced GFR and increased sodium excretion and renal oxygen extraction. We conclude that NO in endotoxemia is beneficial because it maintains RBF and GFR. Additionally, selective NOS inhibition did not offer any advantages over saline resuscitation.
一氧化氮(NO)被认为在脓毒症所致肾衰竭的病理生理学中起关键作用。NO增加对肾脏的影响是有益还是有害仍不清楚。在脂多糖(LPS)诱导的猪休克模型中,我们评估了LPS对肾小球滤过率(GFR)和肾血流量(RBF)的影响。然后我们给予非选择性一氧化氮合酶(NOS)抑制剂N(G)-L-精氨酸甲酯(L-NAME),并将其对GFR和RBF的影响与选择性NOS抑制剂S-甲基异硫脲(SMT)以及生理盐水的影响进行比较。我们推测,通过维持内源性NO,SMT比L-NAME或生理盐水更有益。输注LPS降低了平均动脉压(MAP),增加了心输出量、RBF和髓质NO含量。增加的RBF转向髓质。在生理盐水复苏组中没有肾功能障碍的证据。两种NOS抑制剂均增加了MAP,但降低了RBF,但只有L-NAME降低了GFR并增加了钠排泄和肾脏氧摄取。我们得出结论,内毒素血症中的NO是有益的,因为它维持了RBF和GFR。此外,选择性NOS抑制与生理盐水复苏相比没有任何优势。